e-learning
resources
Vienna 2009
Monday, 14.09.2009
Pathology and immunology of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Smoking has potential to initiate basement membrane disruption and epithelial mesenchymal transition in COPD
S. S. Sohal, D. Reid, A. Soltani, C. Ward, S. Weston, H. Muller, R. Wood-Baker, H. Walters (Hobart, Australia; Newcastle Upon Tyne, United Kingdom)
Source:
Annual Congress 2009 - Pathology and immunology of COPD
Session:
Pathology and immunology of COPD
Session type:
Oral Presentation
Number:
1603
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. S. Sohal, D. Reid, A. Soltani, C. Ward, S. Weston, H. Muller, R. Wood-Baker, H. Walters (Hobart, Australia; Newcastle Upon Tyne, United Kingdom). Smoking has potential to initiate basement membrane disruption and epithelial mesenchymal transition in COPD. Eur Respir J 2009; 34: Suppl. 53, 1603
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Definition and history of sarcoidosis
Related content which might interest you:
Vascular and basement membrane remodelling in smokers and COPD
Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Year: 2009
Epithelial fibroblast triggering and interactions in pulmonary fibrosis
Source: Eur Respir Rev 2008; 17: 123-129
Year: 2008
The role of epithelial to mesenchymal transition (EMT) in airway remodelling after human lung transplantation
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008
The injury extension to the epithelial cell/epithelial basement membrane unity (EC-EBM) as the major pathogenetic determinant of lung architectural remodelling in IIP: a paradigmatic change
Source: Eur Respir J 2004; 24: Suppl. 48, 557s
Year: 2004
Epithelial to mesenchymal transition in basal progenitor epithelial cells cultured from smokers and COPD patients
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015
Normal development of the bronchial epithelial reticular basement membrane (rbm)
Source: Annual Congress 2009 - New data on respiratory function - from experimental approaches to man
Year: 2009
Cigarette smoke impairs airway epithelial barrier function and cell–cell contact recovery
Source: Eur Respir J 2012; 39: 419-428
Year: 2012
Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition
Source: Eur Respir J 2015; 45: 1258-1272
Year: 2015
Altered composition of airway basement membranes in COPD
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011
COPD-related epithelial inflammation drives EMT in primary epithelial ALI-cultures
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018
Epithelial Pten controls acute lung injury and fibrosis by regulating intercellular junctional integrity and EMT
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Mechanistic target of rapamycin enhances fibrosis in lung by promoting epithelial mesenchymal transition
Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2019
Epithelial mesenchymal transition (EMT) related changes in small airways of smokers and patients with COPD
Source: Virtual Congress 2021 – Pathogenic progress in airway diseases
Year: 2021
Hypoxia-induced EMT in primary human small airway epithelium is controlled by extracellular matrix interactions
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
Downregulation of lysosome-associated membrane protein-2A accelerates cigarette smoke extract-induced aging and apoptosis in human bronchial epithelial cells
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype
Source: Eur Respir Rev 2014; 23: 118-130
Year: 2014
TGFβ-induced epithelial to mesenchymal transition (EMT) as a model of COPD
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
Basement membrane, a specialized extracellular matrix, shapes endothelial function in IPAH
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020
Noneosinophilic asthma in children: relation with airway remodelling
Source: Eur Respir J 2011; 38: 575-583
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept